ゲノミクス市場：製品・サービス、テクノロジー、エンドユーザー、アプリケーション別-2025-2030年の世界予測

ゲノミクス市場は、2023年に273億6,000万米ドルと評価され、2024年には315億1,000万米ドルに達すると予測され、CAGR 15.63％で成長し、2030年には756億3,000万米ドルに達すると予測されています。

ゲノミクス市場には、ゲノムのシーケンス、解析、編集を扱う技術の研究、開発、応用が含まれます。個別化医療、農業の進歩、バイオテクノロジーの革新に不可欠です。ゲノミクスの必要性は、正確な医療介入を可能にし、病気のかかりやすさを予測し、標的療法を開発することでヘルスケアに革命をもたらす可能性にあります。ヘルスケアにとどまらず、遺伝子工学、生物多様性保全、法医学などの分野にも応用されています。新たな最終用途分野としては、製薬会社、研究所、学術機関、バイオテクノロジー企業などが挙げられます。市場成長を促進する主な要因としては、シーケンス技術の進歩、シーケンスコストの低下、個別化医療に対する需要の増加などが挙げられます。さらに、ゲノム研究を支援する政府の取り組みや、研究機関と主要市場プレーヤー間の協力関係の急増が、この市場をさらに刺激しています。潜在的なビジネスチャンスとしては、ヘルスケアインフラの近代化が進んでいる発展途上国での拡大、ゲノムデータ解析の精度とスピードを高めるためのAIと機械学習の統合などが挙げられます。ゲノミクス市場が直面する課題には、遺伝子データのプライバシーに関する倫理的懸念、規制上のハードル、データ管理の複雑さなどがあります。さらに、ゲノミクス技術の熟練した専門家の不足は、市場の成長を鈍らせる可能性があります。CRISPR技術、新規治療薬、消費者にやさしいゲノム検査キットの開発における革新と研究は、事業成長の有望な道筋を示しています。データ・セキュリティの向上、バイオインフォマティクス・ツールの進歩、遺伝子データ管理のための強固なフレームワークの確立に注力している企業は、戦略的に大きな優位性を見出すことができそうです。市場力学はダイナミックで競争が激しく、急速な技術進歩と継続的な新規参入を特徴とします。戦略的パートナーシップの構築、倫理的懸念への対処、熟練した人材開拓への投資は、この新興国市場の機会を活用するための推奨戦略です。

市場力学：急速に進化するゲノミクス市場の主要市場インサイトを公開

ゲノミクス市場は、需要と供給のダイナミックな相互作用によって変貌を遂げています。このような市場力学の進化を理解することで、企業は十分な情報に基づいた投資決定、戦略的意思決定、新たなビジネスチャンスの獲得を行うことができます。これらの動向を包括的に把握することで、企業は政治的、地理的、技術的、社会的、経済的な領域にわたる様々なリスクを軽減することができ、また、消費者行動とそれが製造コストや購買動向に与える影響をより明確に理解することができます。

• 市場促進要因
  • ゲノム・プロジェクトの研究開発に対する政府資金の増加
  • ゲノム医療と精密公衆衛生の採用拡大
  • アグリゲノミクスにおける遺伝子ツールの開発
• 市場抑制要因
  • 機器や消耗品の高コスト
• 市場機会
  • 新生児遺伝子スクリーニングプログラムとシーケンス技術の成長
  • 革新的な製品やサービスを発売するための高度な計算技術の採用
• 市場の課題
  • 熟練した訓練された人材の不足

ポーターの5つの力：ゲノミクス市場をナビゲートする戦略ツール

ポーターの5つの力フレームワークは、ゲノミクス市場の競合情勢を理解するための重要なツールです。ポーターのファイブフォース・フレームワークは、企業の競争力を評価し、戦略的機会を探るための明確な手法を提供します。このフレームワークは、企業が市場内の勢力図を評価し、新規事業の収益性を判断するのに役立ちます。これらの洞察により、企業は自社の強みを活かし、弱みに対処し、潜在的な課題を回避することができ、より強靭な市場でのポジショニングを確保することができます。

PESTLE分析：ゲノミクス市場における外部からの影響の把握

外部マクロ環境要因は、ゲノミクス市場の業績ダイナミクスを形成する上で極めて重要な役割を果たします。政治的、経済的、社会的、技術的、法的、環境的要因の分析は、これらの影響をナビゲートするために必要な情報を提供します。PESTLE要因を調査することで、企業は潜在的なリスクと機会をよりよく理解することができます。この分析により、企業は規制、消費者の嗜好、経済動向の変化を予測し、先を見越した積極的な意思決定を行う準備ができます。

市場シェア分析ゲノミクス市場における競合情勢の把握

ゲノミクス市場の詳細な市場シェア分析により、ベンダーの業績を包括的に評価することができます。企業は、収益、顧客ベース、成長率などの主要指標を比較することで、競争上のポジショニングを明らかにすることができます。この分析により、市場の集中、断片化、統合の動向が明らかになり、ベンダーは競争が激化する中で自社の地位を高める戦略的意思決定を行うために必要な知見を得ることができます。

FPNVポジショニング・マトリックスゲノミクス市場におけるベンダーのパフォーマンス評価

FPNVポジショニングマトリックスは、ゲノミクス市場においてベンダーを評価するための重要なツールです。このマトリックスにより、ビジネス組織はベンダーのビジネス戦略と製品満足度に基づき評価することで、目標に沿った十分な情報に基づいた意思決定を行うことができます。4つの象限によってベンダーを明確かつ正確にセグメント化し、戦略目標に最適なパートナーやソリューションを特定することができます。

戦略分析と推奨ゲノミクス市場における成功への道筋を描く

ゲノミクス市場の戦略分析は、世界市場でのプレゼンス強化を目指す企業にとって不可欠です。主要なリソース、能力、業績指標を検討することで、企業は成長機会を特定し、改善に取り組むことができます。このアプローチにより、競合情勢における課題を克服し、新たなビジネスチャンスを活かして長期的な成功を収めるための体制を整えることができます。

本レポートでは、主要な注目分野を網羅した市場の包括的な分析を提供しています：

1.市場の浸透度：現在の市場環境の詳細なレビュー、主要企業による広範なデータ、市場でのリーチと全体的な影響力の評価。

2.市場の開拓度：新興市場における成長機会を特定し、既存分野における拡大可能性を評価し、将来の成長に向けた戦略的ロードマップを提供します。

3.市場の多様化：最近の製品発売、未開拓の地域、業界の主要な進歩、市場を形成する戦略的投資を分析します。

4.競合の評価と情報：競合情勢を徹底的に分析し、市場シェア、事業戦略、製品ポートフォリオ、認証、規制当局の承認、特許動向、主要企業の技術進歩などを検証します。

5.製品開発およびイノベーション：将来の市場成長を促進すると期待される最先端技術、研究開発活動、製品イノベーションをハイライトしています。

また、利害関係者が十分な情報を得た上で意思決定できるよう、重要な質問にも答えています：

1.現在の市場規模と今後の成長予測は？

2.最高の投資機会を提供する製品、セグメント、地域はどこか？

3.市場を形成する主な技術動向と規制の影響とは？

4.主要ベンダーの市場シェアと競合ポジションは？

5.ベンダーの市場参入・撤退戦略の原動力となる収益源と戦略的機会は何か？

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

• 市場力学
  • 促進要因
    • ゲノムプロジェクトの研究開発に対する政府資金の増加
    • ゲノム医療と精密公衆衛生の導入拡大
    • アグリゲノミクスにおける遺伝子ツールの開発
  • 抑制要因
    • 機器や消耗品のコストが高い
  • 機会
    • 新生児遺伝子スクリーニングプログラムとシークエンシング技術の成長
    • 革新的な製品やサービスを立ち上げるための高度な計算技術の採用
  • 課題
    • 熟練した訓練を受けた人材が限られている
• 市場セグメンテーション分析
• ポーターのファイブフォース分析
• PESTEL分析
  • 政治的
  • 経済
  • 社交
  • 技術的
  • 法律上
  • 環境

第6章 ゲノミクス市場：製品・サービス別

• 消耗品
• サービス
• システムとソフトウェア

第7章 ゲノミクス市場：技術別

• マイクロアレイ
• 核酸抽出と精製
• PCR
• シーケンシング

第8章 ゲノミクス市場：エンドユーザー別

• 政府機関
• 病院・クリニック
• 製薬・バイオテクノロジー企業
• 研究センターと学術

第9章 ゲノミクス市場：用途別

• 農業と動物調査
• 診断
• 医薬品の発見と開発

第10章 南北アメリカのゲノミクス市場

• アルゼンチン
• ブラジル
• カナダ
• メキシコ
• 米国

第11章 アジア太平洋地域のゲノミクス市場

• オーストラリア
• 中国
• インド
• インドネシア
• 日本
• マレーシア
• フィリピン
• シンガポール
• 韓国
• 台湾
• タイ
• ベトナム

第12章 欧州・中東・アフリカのゲノミクス市場

• デンマーク
• エジプト
• フィンランド
• フランス
• ドイツ
• イスラエル
• イタリア
• オランダ
• ナイジェリア
• ノルウェー
• ポーランド
• カタール
• ロシア
• サウジアラビア
• 南アフリカ
• スペイン
• スウェーデン
• スイス
• トルコ
• アラブ首長国連邦
• 英国

第13章 競合情勢

• 市場シェア分析2023
• FPNVポジショニングマトリックス, 2023
• 競合シナリオ分析
• 戦略分析と提言

企業一覧

• 10x Genomics, Inc.
• Agilent Technologies, Inc.
• Bio-Rad Laboratories, Inc.
• Biomatters Limited
• Bionano Genomics, Inc.
• C2i Genomics
• Congenica Ltd.
• Danaher Corporation
• Dante Labs Inc.
• Eagle Genomics
• Eppendorf SE
• Eurofins Scientific SE
• F. Hoffmann-La Roche AG
• Fabric Genomics, Inc.
• Helix OpCo, LLC
• Merck & Co., Inc.
• Myriad Genetics, Inc.
• Nest Health Tech Inc.
• Novogene Co., Ltd.
• Oxford Nanopore Technologies PLC
• Pacific Biosciences of California, Inc.
• Personalis, Inc.
• QIAGEN GmbH
• Quest Diagnostics Incorporated
• Rapid Genomics by LGC Biosearch Technologies
• Thermo Fisher Scientific Inc.
• Vizgen, Inc.

LIST OF FIGURES

• FIGURE 1. GENOMICS MARKET RESEARCH PROCESS
• FIGURE 2. GENOMICS MARKET SIZE, 2023 VS 2030
• FIGURE 3. GLOBAL GENOMICS MARKET SIZE, 2018-2030 (USD MILLION)
• FIGURE 4. GLOBAL GENOMICS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 5. GLOBAL GENOMICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 6. GLOBAL GENOMICS MARKET SIZE, BY PRODUCT & SERVICE, 2023 VS 2030 (%)
• FIGURE 7. GLOBAL GENOMICS MARKET SIZE, BY PRODUCT & SERVICE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 8. GLOBAL GENOMICS MARKET SIZE, BY TECHNOLOGY, 2023 VS 2030 (%)
• FIGURE 9. GLOBAL GENOMICS MARKET SIZE, BY TECHNOLOGY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 10. GLOBAL GENOMICS MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
• FIGURE 11. GLOBAL GENOMICS MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 12. GLOBAL GENOMICS MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
• FIGURE 13. GLOBAL GENOMICS MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 14. AMERICAS GENOMICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 15. AMERICAS GENOMICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 16. UNITED STATES GENOMICS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
• FIGURE 17. UNITED STATES GENOMICS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 18. ASIA-PACIFIC GENOMICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 19. ASIA-PACIFIC GENOMICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 20. EUROPE, MIDDLE EAST & AFRICA GENOMICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
• FIGURE 21. EUROPE, MIDDLE EAST & AFRICA GENOMICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
• FIGURE 22. GENOMICS MARKET SHARE, BY KEY PLAYER, 2023
• FIGURE 23. GENOMICS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

• TABLE 1. GENOMICS MARKET SEGMENTATION & COVERAGE
• TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
• TABLE 3. GLOBAL GENOMICS MARKET SIZE, 2018-2030 (USD MILLION)
• TABLE 4. GLOBAL GENOMICS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 5. GLOBAL GENOMICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 6. GENOMICS MARKET DYNAMICS
• TABLE 7. GLOBAL GENOMICS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 8. GLOBAL GENOMICS MARKET SIZE, BY CONSUMABLES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 9. GLOBAL GENOMICS MARKET SIZE, BY SERVICES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 10. GLOBAL GENOMICS MARKET SIZE, BY SYSTEMS & SOFTWARE, BY REGION, 2018-2030 (USD MILLION)
• TABLE 11. GLOBAL GENOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 12. GLOBAL GENOMICS MARKET SIZE, BY MICROARRAY, BY REGION, 2018-2030 (USD MILLION)
• TABLE 13. GLOBAL GENOMICS MARKET SIZE, BY NUCLEIC ACID EXTRACTION & PURIFICATION, BY REGION, 2018-2030 (USD MILLION)
• TABLE 14. GLOBAL GENOMICS MARKET SIZE, BY PCR, BY REGION, 2018-2030 (USD MILLION)
• TABLE 15. GLOBAL GENOMICS MARKET SIZE, BY SEQUENCING, BY REGION, 2018-2030 (USD MILLION)
• TABLE 16. GLOBAL GENOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 17. GLOBAL GENOMICS MARKET SIZE, BY GOVERNMENT INSTITUTES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 18. GLOBAL GENOMICS MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 19. GLOBAL GENOMICS MARKET SIZE, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2018-2030 (USD MILLION)
• TABLE 20. GLOBAL GENOMICS MARKET SIZE, BY RESEARCH CENTERS & ACADEMIC, BY REGION, 2018-2030 (USD MILLION)
• TABLE 21. GLOBAL GENOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 22. GLOBAL GENOMICS MARKET SIZE, BY AGRICULTURE & ANIMAL RESEARCH, BY REGION, 2018-2030 (USD MILLION)
• TABLE 23. GLOBAL GENOMICS MARKET SIZE, BY DIAGNOSTICS, BY REGION, 2018-2030 (USD MILLION)
• TABLE 24. GLOBAL GENOMICS MARKET SIZE, BY DRUG DISCOVERY & DEVELOPMENT, BY REGION, 2018-2030 (USD MILLION)
• TABLE 25. AMERICAS GENOMICS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 26. AMERICAS GENOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 27. AMERICAS GENOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 28. AMERICAS GENOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 29. AMERICAS GENOMICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 30. ARGENTINA GENOMICS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 31. ARGENTINA GENOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 32. ARGENTINA GENOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 33. ARGENTINA GENOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 34. BRAZIL GENOMICS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 35. BRAZIL GENOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 36. BRAZIL GENOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 37. BRAZIL GENOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 38. CANADA GENOMICS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 39. CANADA GENOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 40. CANADA GENOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 41. CANADA GENOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 42. MEXICO GENOMICS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 43. MEXICO GENOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 44. MEXICO GENOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 45. MEXICO GENOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 46. UNITED STATES GENOMICS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 47. UNITED STATES GENOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 48. UNITED STATES GENOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 49. UNITED STATES GENOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 50. UNITED STATES GENOMICS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
• TABLE 51. ASIA-PACIFIC GENOMICS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 52. ASIA-PACIFIC GENOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 53. ASIA-PACIFIC GENOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 54. ASIA-PACIFIC GENOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 55. ASIA-PACIFIC GENOMICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 56. AUSTRALIA GENOMICS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 57. AUSTRALIA GENOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 58. AUSTRALIA GENOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 59. AUSTRALIA GENOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 60. CHINA GENOMICS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 61. CHINA GENOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 62. CHINA GENOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 63. CHINA GENOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 64. INDIA GENOMICS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 65. INDIA GENOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 66. INDIA GENOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 67. INDIA GENOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 68. INDONESIA GENOMICS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 69. INDONESIA GENOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 70. INDONESIA GENOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 71. INDONESIA GENOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 72. JAPAN GENOMICS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 73. JAPAN GENOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 74. JAPAN GENOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 75. JAPAN GENOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 76. MALAYSIA GENOMICS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 77. MALAYSIA GENOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 78. MALAYSIA GENOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 79. MALAYSIA GENOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 80. PHILIPPINES GENOMICS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 81. PHILIPPINES GENOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 82. PHILIPPINES GENOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 83. PHILIPPINES GENOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 84. SINGAPORE GENOMICS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 85. SINGAPORE GENOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 86. SINGAPORE GENOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 87. SINGAPORE GENOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 88. SOUTH KOREA GENOMICS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 89. SOUTH KOREA GENOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 90. SOUTH KOREA GENOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 91. SOUTH KOREA GENOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 92. TAIWAN GENOMICS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 93. TAIWAN GENOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 94. TAIWAN GENOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 95. TAIWAN GENOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 96. THAILAND GENOMICS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 97. THAILAND GENOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 98. THAILAND GENOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 99. THAILAND GENOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 100. VIETNAM GENOMICS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 101. VIETNAM GENOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 102. VIETNAM GENOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 103. VIETNAM GENOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 104. EUROPE, MIDDLE EAST & AFRICA GENOMICS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 105. EUROPE, MIDDLE EAST & AFRICA GENOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 106. EUROPE, MIDDLE EAST & AFRICA GENOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 107. EUROPE, MIDDLE EAST & AFRICA GENOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 108. EUROPE, MIDDLE EAST & AFRICA GENOMICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
• TABLE 109. DENMARK GENOMICS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 110. DENMARK GENOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 111. DENMARK GENOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 112. DENMARK GENOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 113. EGYPT GENOMICS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 114. EGYPT GENOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 115. EGYPT GENOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 116. EGYPT GENOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 117. FINLAND GENOMICS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 118. FINLAND GENOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 119. FINLAND GENOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 120. FINLAND GENOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 121. FRANCE GENOMICS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 122. FRANCE GENOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 123. FRANCE GENOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 124. FRANCE GENOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 125. GERMANY GENOMICS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 126. GERMANY GENOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 127. GERMANY GENOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 128. GERMANY GENOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 129. ISRAEL GENOMICS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 130. ISRAEL GENOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 131. ISRAEL GENOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 132. ISRAEL GENOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 133. ITALY GENOMICS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 134. ITALY GENOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 135. ITALY GENOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 136. ITALY GENOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 137. NETHERLANDS GENOMICS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 138. NETHERLANDS GENOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 139. NETHERLANDS GENOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 140. NETHERLANDS GENOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 141. NIGERIA GENOMICS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 142. NIGERIA GENOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 143. NIGERIA GENOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 144. NIGERIA GENOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 145. NORWAY GENOMICS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 146. NORWAY GENOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 147. NORWAY GENOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 148. NORWAY GENOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 149. POLAND GENOMICS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 150. POLAND GENOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 151. POLAND GENOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 152. POLAND GENOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 153. QATAR GENOMICS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 154. QATAR GENOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 155. QATAR GENOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 156. QATAR GENOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 157. RUSSIA GENOMICS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 158. RUSSIA GENOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 159. RUSSIA GENOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 160. RUSSIA GENOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 161. SAUDI ARABIA GENOMICS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 162. SAUDI ARABIA GENOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 163. SAUDI ARABIA GENOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 164. SAUDI ARABIA GENOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 165. SOUTH AFRICA GENOMICS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 166. SOUTH AFRICA GENOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 167. SOUTH AFRICA GENOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 168. SOUTH AFRICA GENOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 169. SPAIN GENOMICS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 170. SPAIN GENOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 171. SPAIN GENOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 172. SPAIN GENOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 173. SWEDEN GENOMICS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 174. SWEDEN GENOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 175. SWEDEN GENOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 176. SWEDEN GENOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 177. SWITZERLAND GENOMICS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 178. SWITZERLAND GENOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 179. SWITZERLAND GENOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 180. SWITZERLAND GENOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 181. TURKEY GENOMICS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 182. TURKEY GENOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 183. TURKEY GENOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 184. TURKEY GENOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 185. UNITED ARAB EMIRATES GENOMICS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 186. UNITED ARAB EMIRATES GENOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 187. UNITED ARAB EMIRATES GENOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 188. UNITED ARAB EMIRATES GENOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 189. UNITED KINGDOM GENOMICS MARKET SIZE, BY PRODUCT & SERVICE, 2018-2030 (USD MILLION)
• TABLE 190. UNITED KINGDOM GENOMICS MARKET SIZE, BY TECHNOLOGY, 2018-2030 (USD MILLION)
• TABLE 191. UNITED KINGDOM GENOMICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
• TABLE 192. UNITED KINGDOM GENOMICS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
• TABLE 193. GENOMICS MARKET SHARE, BY KEY PLAYER, 2023
• TABLE 194. GENOMICS MARKET, FPNV POSITIONING MATRIX, 2023

The Genomics Market was valued at USD 27.36 billion in 2023, expected to reach USD 31.51 billion in 2024, and is projected to grow at a CAGR of 15.63%, to USD 75.63 billion by 2030.

The genomics market encompasses the research, development, and application of technologies that deal with the sequencing, analysis, and editing of genomes. It is integral for personalized medicine, agricultural advancements, and biotechnology innovations. The necessity of genomics lies in its potential to revolutionize healthcare by enabling precise medical interventions, predicting disease susceptibility, and developing targeted therapies. Beyond healthcare, its application extends to areas such as genetic engineering, biodiversity conservation, and forensic science. Emerging end-use sectors include pharmaceutical companies, research centers, academic institutions, and biotechnological companies. Key factors driving market growth include advancements in sequencing technologies, decreasing costs of sequencing, and an increasing demand for personalized medicine. Additionally, government initiatives supporting genomic research and a surge in collaborations between research institutions and key market players further stimulate this market. Potential opportunities include expansion in developing countries where healthcare infrastructure modernization is underway and the integration of AI and machine learning to enhance genomic data analysis accuracy and speed. Challenges facing the genomics market include ethical concerns over genetic data privacy, regulatory hurdles, and the complexity of data management. Furthermore, a lack of skilled professionals in genomics technology can slow market growth. Innovations and research in CRISPR technologies, novel therapeutics, and the development of consumer-friendly genomic testing kits present promising avenues for business growth. Companies focusing on improving data security, advancing bioinformatics tools, and establishing robust frameworks for genetic data management are likely to find significant strategic advantages. The nature of the genomics market is dynamic and highly competitive, characterized by rapid technological advancements and continuous new entrants. Building strategic partnerships, addressing ethical concerns, and investing in skilled workforce development are recommended strategies for leveraging opportunities in this evolving market.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Genomics Market

The Genomics Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Rising number of government funding for the R&D in genome projects
  • Growing adoption of genomic medicine and precision public health
  • Development of genetic tools in agrigenomics
• Market Restraints
  • High cost of equipment and consumables
• Market Opportunities
  • Growth of newborn genetic screening programs and sequencing technologies
  • Adoption of advanced computational technologies to launch innovative products and services
• Market Challenges
  • Limited skilled and trained personnel

Porter's Five Forces: A Strategic Tool for Navigating the Genomics Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Genomics Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Genomics Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Genomics Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Genomics Market

A detailed market share analysis in the Genomics Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Genomics Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Genomics Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Genomics Market

A strategic analysis of the Genomics Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Genomics Market, highlighting leading vendors and their innovative profiles. These include 10x Genomics, Inc., Agilent Technologies, Inc., Bio-Rad Laboratories, Inc., Biomatters Limited, Bionano Genomics, Inc., C2i Genomics, Congenica Ltd., Danaher Corporation, Dante Labs Inc., Eagle Genomics, Eppendorf SE, Eurofins Scientific SE, F. Hoffmann-La Roche AG, Fabric Genomics, Inc., Helix OpCo, LLC, Merck & Co., Inc., Myriad Genetics, Inc., Nest Health Tech Inc., Novogene Co., Ltd., Oxford Nanopore Technologies PLC, Pacific Biosciences of California, Inc., Personalis, Inc., QIAGEN GmbH, Quest Diagnostics Incorporated, Rapid Genomics by LGC Biosearch Technologies, Thermo Fisher Scientific Inc., and Vizgen, Inc..

Market Segmentation & Coverage

This research report categorizes the Genomics Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Product & Service, market is studied across Consumables, Services, and Systems & Software.
• Based on Technology, market is studied across Microarray, Nucleic Acid Extraction & Purification, PCR, and Sequencing.
• Based on End-User, market is studied across Government Institutes, Hospitals & Clinics, Pharmaceutical & Biotechnology Companies, and Research Centers & Academic.
• Based on Application, market is studied across Agriculture & Animal Research, Diagnostics, and Drug Discovery & Development.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Rising number of government funding for the R&D in genome projects
    • 5.1.1.2. Growing adoption of genomic medicine and precision public health
    • 5.1.1.3. Development of genetic tools in agrigenomics
  • 5.1.2. Restraints
    • 5.1.2.1. High cost of equipment and consumables
  • 5.1.3. Opportunities
    • 5.1.3.1. Growth of newborn genetic screening programs and sequencing technologies
    • 5.1.3.2. Adoption of advanced computational technologies to launch innovative products and services
  • 5.1.4. Challenges
    • 5.1.4.1. Limited skilled and trained personnel
• 5.2. Market Segmentation Analysis
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Genomics Market, by Product & Service

• 6.1. Introduction
• 6.2. Consumables
• 6.3. Services
• 6.4. Systems & Software

7. Genomics Market, by Technology

• 7.1. Introduction
• 7.2. Microarray
• 7.3. Nucleic Acid Extraction & Purification
• 7.4. PCR
• 7.5. Sequencing

8. Genomics Market, by End-User

• 8.1. Introduction
• 8.2. Government Institutes
• 8.3. Hospitals & Clinics
• 8.4. Pharmaceutical & Biotechnology Companies
• 8.5. Research Centers & Academic

9. Genomics Market, by Application

• 9.1. Introduction
• 9.2. Agriculture & Animal Research
• 9.3. Diagnostics
• 9.4. Drug Discovery & Development

10. Americas Genomics Market

• 10.1. Introduction
• 10.2. Argentina
• 10.3. Brazil
• 10.4. Canada
• 10.5. Mexico
• 10.6. United States

11. Asia-Pacific Genomics Market

• 11.1. Introduction
• 11.2. Australia
• 11.3. China
• 11.4. India
• 11.5. Indonesia
• 11.6. Japan
• 11.7. Malaysia
• 11.8. Philippines
• 11.9. Singapore
• 11.10. South Korea
• 11.11. Taiwan
• 11.12. Thailand
• 11.13. Vietnam

12. Europe, Middle East & Africa Genomics Market

• 12.1. Introduction
• 12.2. Denmark
• 12.3. Egypt
• 12.4. Finland
• 12.5. France
• 12.6. Germany
• 12.7. Israel
• 12.8. Italy
• 12.9. Netherlands
• 12.10. Nigeria
• 12.11. Norway
• 12.12. Poland
• 12.13. Qatar
• 12.14. Russia
• 12.15. Saudi Arabia
• 12.16. South Africa
• 12.17. Spain
• 12.18. Sweden
• 12.19. Switzerland
• 12.20. Turkey
• 12.21. United Arab Emirates
• 12.22. United Kingdom

13. Competitive Landscape

• 13.1. Market Share Analysis, 2023
• 13.2. FPNV Positioning Matrix, 2023
• 13.3. Competitive Scenario Analysis
• 13.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. 10x Genomics, Inc.
• 2. Agilent Technologies, Inc.
• 3. Bio-Rad Laboratories, Inc.
• 4. Biomatters Limited
• 5. Bionano Genomics, Inc.
• 6. C2i Genomics
• 7. Congenica Ltd.
• 8. Danaher Corporation
• 9. Dante Labs Inc.
• 10. Eagle Genomics
• 11. Eppendorf SE
• 12. Eurofins Scientific SE
• 13. F. Hoffmann-La Roche AG
• 14. Fabric Genomics, Inc.
• 15. Helix OpCo, LLC
• 16. Merck & Co., Inc.
• 17. Myriad Genetics, Inc.
• 18. Nest Health Tech Inc.
• 19. Novogene Co., Ltd.
• 20. Oxford Nanopore Technologies PLC
• 21. Pacific Biosciences of California, Inc.
• 22. Personalis, Inc.
• 23. QIAGEN GmbH
• 24. Quest Diagnostics Incorporated
• 25. Rapid Genomics by LGC Biosearch Technologies
• 26. Thermo Fisher Scientific Inc.
• 27. Vizgen, Inc.